By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its fourth-quarter molecular diagnostics sales increased 21 percent year over year.

Abbott's total diagnostics sales were $1.02 billion for the quarter, up 4 percent year over year.

Its molecular diagnostics sales contributed $114 million to that total and were up 21 percent. Its US molecular diagnostics sales were $55 million, up 32 percent, and its international sales were up roughly 13 percent at $59 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.